secwatch.observer — SEC 8-K summary
======================================

Issuer:     REVELATION BIOSCIENCES, INC. (REVB)
CIK:        0001810560
Form:       8-K
Filed at:   2024-12-12T23:59:59+00:00
Accession:  0000950170-24-135895
Event type: regulatory
Sentiment:  positive
Materiality: 0.75
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Revelation Biosciences regains compliance with Nasdaq stockholders' equity requirement
--------------------------------------------------------------------------------

- Reported stockholders' equity of $2.67M as of Sep 30, 2024, meeting the $2.5M minimum.
- Entered warrant inducement letters on Dec 3, 2024; 4,064,040 warrants exercised at $1.00/share.
- Gross proceeds from warrant exercises approximately $4.1M; equity now ~$6.0M, cash ~$7.1M.
- Company believes it is compliant with Nasdaq Listing Rule 5550(b)(1) as of Dec 12, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1810560/000095017024135895/0000950170-24-135895-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1810560/000095017024135895/revb-20241212.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-135895

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer